194 related articles for article (PubMed ID: 9351560)
1. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
Brawley OW
Cancer; 1997 Nov; 80(9):1857-63. PubMed ID: 9351560
[TBL] [Abstract][Full Text] [Related]
2. Changes in prostate cancer incidence and treatment in USA.
Lu-Yao GL; Greenberg ER
Lancet; 1994 Jan; 343(8892):251-4. PubMed ID: 7905093
[TBL] [Abstract][Full Text] [Related]
3. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.
Smart CR
Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557
[TBL] [Abstract][Full Text] [Related]
4. Analysis of recent trends in prostate cancer incidence and mortality.
Dennis LK; Resnick MI
Prostate; 2000 Mar; 42(4):247-52. PubMed ID: 10679753
[TBL] [Abstract][Full Text] [Related]
5. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
8. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
Schwartz KL; Severson RK; Gurney JG; Montie JE
Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
[TBL] [Abstract][Full Text] [Related]
9. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
10. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.
Feuer EJ; Mariotto A; Merrill R
Cancer; 2002 Aug; 95(4):870-80. PubMed ID: 12209732
[TBL] [Abstract][Full Text] [Related]
11. Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality.
Demers RY; Tiwari A; Wei J; Weiss LK; Severson RK; Montie J
Cancer; 2001 Nov; 92(9):2309-17. PubMed ID: 11745285
[TBL] [Abstract][Full Text] [Related]
12. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
13. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
[TBL] [Abstract][Full Text] [Related]
14. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
[TBL] [Abstract][Full Text] [Related]
15. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
Hoffman RM; Meisner AL; Arap W; Barry M; Shah SK; Zeliadt SB; Wiggins CL
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):259-63. PubMed ID: 26646364
[TBL] [Abstract][Full Text] [Related]
16. Impact of screening on incidence and mortality of prostate cancer in the United States.
Potosky AL; Feuer EJ; Levin DL
Epidemiol Rev; 2001; 23(1):181-6. PubMed ID: 11588846
[TBL] [Abstract][Full Text] [Related]
17. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
Houston KA; King J; Li J; Jemal A
J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database.
Stephenson RA
Urol Clin North Am; 2002 Feb; 29(1):173-81. PubMed ID: 12109343
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.
Sarma AV; Schottenfeld D
Semin Urol Oncol; 2002 Feb; 20(1):3-9. PubMed ID: 11828352
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
